As the dust settles from years of soaring valuations, our focus shifts to new expectations in 2024.
At #LSIUSA24, our expert panelists will unpack the latest developments in valuation and financing, sharing forecasts and current trends that address the 2024 outlook, and provide a deep dive into how these shifts will affect both current and future investment landscapes.
We’ll hear perspectives from:
• Rik Vandevenne (Moderator), Managing Director, RC Capital, a Healthcare focused growth equity fund, currently investing out of its seventh fund.
• Rebecca Raabe, Investment Partner, SPRIG Equity, a growth equity and late-stage venture capital firm dedicated to improving patient outcomes by partnering with best-in-class teams and technologies in the medical technology sector.
• Paul McCreadie, Partner & COO Arboretum Ventures, a venture capital firm specializing in the healthcare sector investing throughout the United States, but with a preference for Midwest opportunities.
• Matthew Schopp, Senior Director, Business Development, Zimmer Biomet, a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health.
We are still accepting registrations for LSI USA ‘24 on March 18-22 in Dana Point, California. Visit our website to learn more and secure your spot: https://lnkd.in/gjgMpMBh